General Atlantic backed Rubicon Research Pvt. Ltd, a specialty pharmaceutical company, on Friday announced the acquisition of Meditab Specialities Ltd’s oral liquid dosage and nasal product manufacturing facility located in Satara, Maharashtra. The Satara facility is a state-of-the-art cGMP compliant and MHRA (UK) inspected production site that enables a strong and diverse pipeline of oral liquids for Rubicon Research. Rubicon Research is an IP-led, specialty pharmaceutical company that develops, manufactures and commercializes its value-added formulations for the global market. Its flagship manufacturing facility at Ambernath has been inspected by leading global health authorities, including the US FDA and UK MHRA.

Source: Mint July 09, 2021 10:07 UTC